Pleurotus ostreatus inhibits proliferation of human breast and colon cancer cells through p53-dependent as well as p53-independent pathway

International Journal of Oncology

Volumn 33, Issue 6, 2008, Pages 1307-1313

  Jedinak, Andrej ^a   Sliva, Daniel ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Breast cancer; Cell proliferation; Mushroom; Prostate cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLINE; KI 67 ANTIGEN; METHANOL; PLEUROTUS OSTREATUS EXTRACT; PROTEIN P15; PROTEIN P18; PROTEIN P19; PROTEIN P21; PROTEIN P27; PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG; CDKN1A PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; TP53 PROTEIN, HUMAN;

AGARICUS BISPORUS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; EDIBLE MUSHROOM; FLAMMULINA VELUTIPES; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LENTINUS EDODES; PLEUROTUS OSTREATUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION; BREAST TUMOR; CELL CYCLE; CELL SHAPE; CELL STRAIN HCT116; CELL STRAIN HT29; CHEMISTRY; COLON TUMOR; DNA MICROARRAY; DOSE RESPONSE; DRUG EFFECT; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METHODOLOGY; PATHOLOGY; PHOSPHORYLATION; PLEUROTUS; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL CYCLE; CELL CYCLE PROTEINS; CELL PROLIFERATION; CELL SHAPE; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HT29 CELLS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; PLEUROTUS; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 59049106559     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000122     Document Type: Article

References (29)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin 58: 71-96, 2008.
2. Lim DY, Tyner AL, Park JB, Lee JY, Choi YH and Park JH: Inhibition of colon cancer cell proliferation by the dietary compound conjugated linoleic acid is mediated by the CDK inhibitor p21CIP1/WAF1. J Cell Physiol 205: 107-113, 2005.
3. Rajewska J and Balasinska B: Biologically active compounds of edible mushrooms and their beneficial impact on health. Postepy Hig Med Dosw 58: 352-357, 2004.
4. Poucheret P, Fons F and Rapior S: Biological and pharmacological activity of higher fungi: 20-Year retrospective analysis. Cryptog Mycol 27: 311-333, 2006.
5. Ajith TA and Janardhanan KK: Indian medicinal mushrooms as a source of antioxidant and antitumor agents. J Clin Biochem Nutr 40: 157-162, 2007.
6. Sliva D, Jedinak A, Kawasaki J, Harvey K and Slivova V: Phellinus linteus suppresses growth, angiogenesis and invasive behaviour of breast cancer cells through the inhibition of AKT signalling. Br J Cancer 98: 1348-1356, 2008.
7. Sarangi I, Ghosh D, Bhutia SK, Mallick SK and Maiti TK: Anti-tumor and immunomodulating effects of Pleurotus ostreatus mycelia-derived proteoglycans. Int Immunopharmacol 6: 1287-1297, 2006.
8. Gu YH and Leonard J: In vitro effects on proliferation, apoptosis and colony inhibition in ER-dependent and ER-independent human breast cancer cells by selected mushroom species. Oncol Rep 15: 417-423, 2006.
9. Bobek P and Galbavy S: Hypocholesterolemic and antiatherogenic effect of oyster mushroom (Pleurotus ostreatus) in rabbits. Nahrung 43: 339-342, 1999.
10. Bobek P, Ozdin L and Kuniak L: Antioxidative effect of oyster mushroom (Pleurotus ostreatus) in hypercholesterolemic rat. Pharmazie 50: 441-442, 1995.
11. Paulik S, Svrcek J, Mojzisova J, Durove A, Benisek Z and Huska M: The immunomodulatory effect of the soluble fungal glucan (Pleurotus ostreatus) on delayed hypersensitivity and phagocytic ability of blood leucocytes in mice. Zentralbl Veterinarmed B 43: 129-135, 1996.
12. Gu YH and Sivam G: Cytotoxic effect of oyster mushroom Pleurotus ostreatus on human androgen-independent prostate cancer PC-3 cells. J Med Food 9: 196-204, 2006.
13. Lavi I, Friesem D, Geresh S, Hadar Y and Schwartz B: An aqueous polysaccharide extract from the edible mushroom Pleurotus ostreatus induces anti-proliferative and pro-apoptotic effects on HT-29 colon cancer cells. Cancer Lett 244: 61-70, 2006.
14. Jiang J, Slivova V, Valachovicova T, Harvey K and Sliva D: Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3. Int J Oncol 24: 1093-1099, 2004.
15. Sliva D, Harvey K, Mason R, Lloyd F Jr and English D: Effect of phosphatidic acid on human breast cancer cells exposed to doxorubicin. Cancer Invest 19: 783-790, 2001.
16. Mihara K, Cao XR, Yen A, Chandler S, Driscoll B, Murphree AL, T'Ang A and Fung YK: Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science 246: 1300-1303, 1989.
17. Wasser SP. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol 60: 258-274, 2002.
18. Jose N, Ajith TA and Janardhanan KK: Methanol extract of the oyster mushroom, Pleurotus florida, inhibits inflammation and platelet aggregation. Phytother Res 18: 43-46, 2004.
19. Besson A, Dowdy SF and Roberts JM: CDK inhibitors: cell cycle regulators and beyond. Dev Cell 14: 159-169, 2008.
20. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993.
21. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R and Beach D: p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704, 1993.
22. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T and Hannon GJ: Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377: 552-557, 1995.
23. Gartel AL and Tyner AL: Transcriptional regulation of the p21((WAF1/ CIP1)) gene. Exp Cell Res 246: 280-289, 1999.
24. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81: 323-330, 1995.
25. Ohtani K: Implication of transcription factor E2F in regulation of DNA replication. Front Biosci 4: D793-D804, 1999.
26. Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816, 1993.
27. Waga S, Hannon GJ, Beach D and Stillman B: The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369: 574-578, 1994.
28. Paunesku T, Mittal S, Protic M, Oryhon J, Korolev SV, Joachimiak A and Woloschak GE: Proliferating cell nuclear antigen (PCNA): ringmaster of the genome. Int J Radiat Biol 77: 1007-1021, 2001.
29. Dotto GP: p21(WAF1/Cip1): more than a break to the cell cycle? Biochim Biophys Acta 1471: M43-M56, 2000.